Michael C. Jensen
66Patents
14h-index
39Co-inventors
84Inventor score
Filing activity: Apr 6, 1999 → Apr 23, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6410319B1 | CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies | Chemistry; Metallurgy | 293 | Expired |
| US7070995B2 | CE7-specific redirected immune cells | Chemistry; Metallurgy | 223 | Expired |
| US7446191B2 | DNA construct encoding CE7-specific chimeric T cell receptor | Chemistry; Metallurgy | 160 | Active |
| US7265209B2 | CE7-specific chimeric T cell receptor | Chemistry; Metallurgy | 157 | Active |
| US7514537B2 | Chimeric immunoreceptor useful in treating human gliomas | Chemistry; Metallurgy | 151 | Expired |
| US8822647B2 | Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells | Chemistry; Metallurgy | 94 | Active |
| US8802374B2 | Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection | Chemistry; Metallurgy | 93 | Active |
| US8324353B2 | Chimeric immunoreceptor useful in treating human gliomas | Chemistry; Metallurgy | 80 | Active |
| US7354762B2 | Method for producing CE7-specific redirected immune cells | Chemistry; Metallurgy | 78 | Active |
| US9447194B2 | Bispecific chimeric antigen receptors and encoding polynucleotides thereof | Emerging Cross-Sectional Technologies | 70 | Active |
| US8497118B2 | Chimeric immunoreceptor useful in treating human cancers | Chemistry; Metallurgy | 61 | Active |
| US10189903B2 | Bispecific chimeric antigen receptors and methods of use thereof to treat cancer | Emerging Cross-Sectional Technologies | 16 | Active |
| US10266592B2 | Drug regulated transgene expression | Physics | 15 | Active |
| US10780118B2 | Method and compositions for cellular immunotherapy | Chemistry; Metallurgy | 14 | Active |
| US6294513A | Detergent-making process using a high active surfactant paste containing mid-chain branched surfactants | Chemistry; Metallurgy | 14 | Expired |
| US9580685B2 | Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection | Chemistry; Metallurgy | 13 | Active |
| US10736918B2 | Method and compositions for cellular immunotherapy | Chemistry; Metallurgy | 12 | Active |
| US10829556B2 | Polynucleotides encoding bispecific chimeric antigen receptors | Emerging Cross-Sectional Technologies | 11 | Active |
| US11311576B2 | Methods of use for CAR T cells | Chemistry; Metallurgy | 8 | Active |
| US10525082B2 | Genetic engineering of macrophages for immunotherapy | Emerging Cross-Sectional Technologies | 8 | Active |
| US10869889B2 | Method and compositions for cellular immunotherapy | Chemistry; Metallurgy | 6 | Active |
| US10100281B2 | Truncated epiderimal growth factor receptor (EGFRt) for transduced T cell selection | Chemistry; Metallurgy | 6 | Active |
| US10611837B2 | Transgene genetic tags and methods of use | Physics | 6 | Active |
| US10865242B2 | Method and compositions for cellular immunotherapy | Physics | 5 | Active |
| US11779602B2 | Methods of use for CAR T cells | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.